|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hemolytic Uremic Syndrome | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hemolytic-Uremic Syndrome | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Anemia | |||||
| Anemia, Hemolytic | |||||
| Blood Platelet Disorders | |||||
| Disease | |||||
| Hematologic Diseases | |||||
| Kidney Diseases | |||||
| Pathologic Processes | |||||
| Thrombocytopenia | |||||
| Uremia | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| SYNSORB Pk | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
| Long Island Jewish Medical Center | |||||